| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/22/2009 | US7635666 Methods for producing members of specific binding pairs |
| 12/22/2009 | US7635590 Method of diagnosing Lawsonia intracellularis |
| 12/22/2009 | US7635568 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 12/22/2009 | US7635567 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 12/22/2009 | US7635485 Method of accelerated vaccination against Ebola viruses |
| 12/22/2009 | US7635484 Clostridial peptide for preventing or reducing immunoresistance to botulinum toxin therapy in humans and/or other mammals |
| 12/22/2009 | US7635480 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis |
| 12/22/2009 | US7635478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/22/2009 | US7635476 Chimpanzee monoclonal antibodies and antigen binding fragments including variable region peptides; bioassay for detection of hepatitis A virus; diagnosis, treatment and prevention of hepatitis; kits |
| 12/22/2009 | US7635475 Diabody-type bispecific antibody |
| 12/22/2009 | US7635472 single chain antibody construct comprising binding domains specific for human CD3 and human CD19; anticarcinogenic biodrug for treating non-Hodgkin lymphoma |
| 12/22/2009 | CA2417161C Method for immuno-detection of epitopes |
| 12/22/2009 | CA2336541C Modulation of polypeptide display on modified filamentous phage |
| 12/22/2009 | CA2323607C Immunological methods to modulate myostatin in vertebrate subjects |
| 12/22/2009 | CA2234565C Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 12/22/2009 | CA2214636C Use of leukemia inhibitory factor and endothelin antagonists |
| 12/22/2009 | CA2180309C Coccidiosis poultry vaccine |
| 12/22/2009 | CA2133833C Method and kit for imaging and treating organs and tissues |
| 12/22/2009 | CA2104871C Prad1 cyclin (cyclin d1) and its cdna |
| 12/19/2009 | CA2633246A1 Identification of therapeutic agents for hiv infection |
| 12/17/2009 | WO2009152287A1 Use of histamine h4 antagonist for the treatment of post-operative adhesions |
| 12/17/2009 | WO2009151633A1 Novel monoclonal antibodies against hpv proteins |
| 12/17/2009 | WO2009151460A1 Methods of converting fab sequences into single chain antibody sequences |
| 12/17/2009 | WO2009151356A1 Antibodies against extracellular domains 2 and 3 or her2 |
| 12/17/2009 | WO2009151165A1 Recombinant sars-c o v n s p 12 and the use thereof, and the method for producing it |
| 12/17/2009 | WO2009150635A1 Treatment of chronic prostatitis |
| 12/17/2009 | WO2009150623A1 Treatment of chronic prostatitis |
| 12/17/2009 | WO2009150539A2 Variable domains of camelid heavy-chain antibodies directed against androctonus autralis hector toxins |
| 12/17/2009 | WO2009150531A1 Antibodies against neisserial factor h binding protein |
| 12/17/2009 | WO2009150426A2 Method |
| 12/17/2009 | WO2009150295A1 Detection of cannabis use |
| 12/17/2009 | WO2009150275A1 Human anti-dectin-1 antibody, hybridoma producing said antibody and applications thereof |
| 12/17/2009 | WO2009150256A1 Markers for predicting response and survival in anti-egfr treated patients |
| 12/17/2009 | WO2009150255A2 Markers for predicting response and survival in anti-egfr treated patients |
| 12/17/2009 | WO2009149599A1 Liposome medicament and preparation method and use thereof |
| 12/17/2009 | WO2009149562A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 12/17/2009 | WO2009149560A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 12/17/2009 | WO2009130296A3 Anti-alk1 antibodies and uses thereof |
| 12/17/2009 | WO2009128963A3 Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof |
| 12/17/2009 | WO2009120922A3 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 12/17/2009 | WO2009118662A3 Methods and compositions for treating bone loss |
| 12/17/2009 | WO2009105548A3 Methods for treating and diagnosing diabetes |
| 12/17/2009 | WO2009102509A9 Vaccines and diagnostics for ehrlichia chaffeensis |
| 12/17/2009 | WO2009087467A3 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 12/17/2009 | WO2009085209A3 Methods for using and identifying modulators of delta-like 4 |
| 12/17/2009 | WO2008070135A8 Methods of treating systemic lupus erythematosus |
| 12/17/2009 | US20090313711 Novel protein and production process and use thereof |
| 12/17/2009 | US20090312527 Novel monoclonal antibodies against HPV proteins |
| 12/17/2009 | US20090312526 Method for producing antibodies |
| 12/17/2009 | US20090312410 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 12/17/2009 | US20090312263 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/17/2009 | US20090312245 SRA binding protein |
| 12/17/2009 | US20090312190 Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses |
| 12/17/2009 | US20090311806 target substance capturing body comprising a substrate and a protein utilizing an anti-gold antibody and a gold-binding side which is a part of the anti-gold antibody; used for the detection of a target substance |
| 12/17/2009 | US20090311802 Isolated Soluble IL-TIF/IL-22 Receptor or Binding Protein Which Binds to IL-TIF/IL-22 and Uses Thereof |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311780 Minimally immunogenic variants of sdr-grafted humanized antibody cc49 and their use |
| 12/17/2009 | US20090311779 Anti-p-selectin antibodies |
| 12/17/2009 | US20090311745 Group of esterases for the enantioselective production of fine and speciality chemicals |
| 12/17/2009 | US20090311728 Novel Platelet Activation Marker and Method for Determination Thereof |
| 12/17/2009 | US20090311718 Degraded agonist antibody |
| 12/17/2009 | US20090311714 Methods for the Screening of Antibacterial Substances |
| 12/17/2009 | US20090311696 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/17/2009 | US20090311671 Diagnosis of risk of breast cancer |
| 12/17/2009 | US20090311398 Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311280 Novel tnf receptor regulatory domain |
| 12/17/2009 | US20090311274 Polynucleotide coding tumor protein for use as preventive, diagnostic and prognostic tool in treatment of cell proliferative disorders |
| 12/17/2009 | US20090311272 Methods and compositions for modulating angiogenesis and pericyte composition |
| 12/17/2009 | US20090311271 Methods and Compositions for Selective Inhibition of Ligand Binding to the Lectin-Like Receptor for Oxidized Low Density Lipoprotein (LOX-1) |
| 12/17/2009 | US20090311268 Cd40-binding activating antibodies |
| 12/17/2009 | US20090311265 Human binding molecules capable or neutralizing influenze virus h5n1 and uses thereof |
| 12/17/2009 | US20090311263 Human vascular ibp-like growth factor |
| 12/17/2009 | US20090311262 Method for Diagnosing Cancers Expressing the HER2 Receptor or its Truncated Variants |
| 12/17/2009 | US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311259 maytansinoid drug moieties covalently linked by a linker to an antibody which binds to an ErbB receptor, or which binds to one or more tumor-associated antigens or cell-surface receptors; cancer |
| 12/17/2009 | US20090311257 Human antibodies specific for gastrin materials and methods |
| 12/17/2009 | US20090311256 12 Human Secreted Proteins |
| 12/17/2009 | US20090311255 Preventing autoimmune disease |
| 12/17/2009 | US20090311254 Cd40 antibody formulation and methods |
| 12/17/2009 | US20090311253 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 12/17/2009 | US20090311252 Anti-activin antibodies and uses for promoting bone growth |
| 12/17/2009 | US20090311251 Scfv antibodies which pass epithelial and/or endothelial layers |
| 12/17/2009 | US20090311248 Hepatitis C Virus Neutralizing Antibodies |
| 12/17/2009 | US20090311247 Molecules and chimeric molecules thereof |
| 12/17/2009 | US20090311246 Method of Enhancing Remyelination in Demyelinating Diseases of the Central Nervous System |
| 12/17/2009 | US20090311245 Metalloproteinase 9 binding proteins |
| 12/17/2009 | US20090311241 Human antibodies that bind human IL-12 and methods for producing |
| 12/17/2009 | US20090311224 Therapeutic agent comprising lipocalin 2 against cancer metastasis, and methods of early diagnosis and inhibition of cancer metastasis using lipocalin 2 |
| 12/17/2009 | US20090311193 Methods and reagents for in vivo imaging of cancer cell lines |
| 12/17/2009 | US20090311183 Metalloproteinase 12 binding proteins |
| 12/17/2009 | US20090311181 Engineered Anti-Prostate Stem Cell Antigen (PSCA) Antibodies for Cancer Targeting |
| 12/17/2009 | US20090311180 Protein Isoforms and Uses Thereof |
| 12/17/2009 | CA2727941A1 Antibodies against extracellular domains 2 and 3 or her2 |
| 12/17/2009 | CA2727852A1 Treatment of chronic prostatitis |
| 12/17/2009 | CA2727790A1 Reagents and methods for detecting a polymorphic protein |
| 12/17/2009 | CA2727141A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 12/17/2009 | CA2727086A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |